Human medicinehttps://www.ema.europa.eu/en/homepageHuman medicineen-gbCopyright: (C) European Medicines AgencySat, 08 Jun 2024 03:23:28 +0200Tue, 21 May 2024 17:31:00 +0200Rekambys : EPAR - Product informationhttps://www.ema.europa.eu/system/files/documents/product-information/ema-combined-h-5060-en.pdfRekambys : EPAR - Product informationhttps://www.ema.europa.eu/system/files/documents/product-information/ema-combined-h-5060-en.pdfTue, 21 May 2024 17:31:00 +0200Human medicineHuman medicines European public assessment report (EPAR): Rekambys, rilpivirine, Date of authorisation: 17/12/2020, Revision: 10, Status: Authorisedhttps://www.ema.europa.eu/en/medicines/human/EPAR/rekambysHuman medicines European public assessment report (EPAR): Rekambys, rilpivirine, Date of authorisation: 17/12/2020, Revision: 10, Status: Authorisedhttps://www.ema.europa.eu/en/medicines/human/EPAR/rekambysTue, 21 May 2024 09:30:02 +0200Human medicine